HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eckart Fleck Selected Research

tetrapeptide carbamate

11/2005Proprotein convertases furin and PC5: targeting atherosclerosis and restenosis at multiple levels.
5/2005Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-pro-matrix metalloproteinase-2 proteolytic cascade in atherosclerosis.
4/2005Immunohistochemical localization of subtilisin/kexin-like proprotein convertases in human atherosclerosis.
2/2004Endoproteolytic activation of alpha(v) integrin by proprotein convertase PC5 is required for vascular smooth muscle cell adhesion to vitronectin and integrin-dependent signaling.
3/2003Coordinated regulation and colocalization of alphav integrin and its activating enzyme proprotein convertase PC5 in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eckart Fleck Research Topics

Disease

19Coronary Artery Disease (Coronary Atherosclerosis)
05/2015 - 01/2002
15Atherosclerosis
01/2013 - 02/2002
8Heart Failure
08/2013 - 03/2002
8Body Weight (Weight, Body)
02/2012 - 01/2003
5Hypertension (High Blood Pressure)
08/2018 - 10/2010
5Myocardial Ischemia (Ischemic Heart Diseases)
06/2014 - 01/2002
5Myocardial Infarction
01/2014 - 02/2004
5Inflammation (Inflammations)
06/2013 - 01/2008
4Fibrosis (Cirrhosis)
12/2014 - 07/2005
4Cardiovascular Diseases (Cardiovascular Disease)
01/2014 - 01/2008
4Atherosclerotic Plaque (Atheroma)
02/2012 - 02/2004
4Coronary Stenosis (Coronary Artery Stenosis)
01/2011 - 01/2005
4Pathologic Constriction (Stenosis)
01/2011 - 01/2006
4Vascular Diseases (Vascular Disease)
12/2004 - 05/2002
3Atrial Fibrillation
01/2015 - 01/2009
3Death (Near-Death Experience)
01/2014 - 02/2004
3Cicatrix (Scar)
08/2013 - 05/2004
3Neointima
02/2013 - 03/2003
3Obesity
01/2013 - 11/2002
3Heart Arrest (Cardiac Arrest)
03/2011 - 01/2009
3Vascular Remodeling
08/2004 - 03/2003
2Tachycardia (Tachyarrhythmias)
01/2015 - 06/2008
2Hypertrophy
12/2014 - 09/2010
2Vascular System Injuries
02/2010 - 11/2005
2Insulin Resistance
01/2008 - 03/2007
1Phenylketonurias (Phenylketonuria)
01/2021
1Hypothermia
05/2016
1Acute Coronary Syndrome
05/2016
1Out-of-Hospital Cardiac Arrest
05/2016
1Atrial Flutter (Flutter, Atrial)
01/2015
1Aortic Valve Stenosis (Aortic Stenosis)
07/2014
1Chronic Renal Insufficiency
08/2013
1Glucose Intolerance
08/2013
1Fibromuscular Dysplasia
08/2013
1Cardiomyopathies (Cardiomyopathy)
08/2013
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2013
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
10/2010
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
09/2010
1Embolism (Embolus)
09/2009
1Infarction (Infarctions)
04/2009
1Myositis (Idiopathic Inflammatory Myopathies)
03/2009

Drug/Important Bio-Agent (IBA)

16DobutamineFDA LinkGeneric
05/2015 - 01/2002
13GadoliniumIBA
06/2014 - 01/2002
11Adenosine (Adenocard)FDA LinkGeneric
03/2011 - 01/2002
7FurinIBA
02/2013 - 03/2003
6Gadolinium DTPA (Magnevist)FDA Link
01/2012 - 01/2003
6IntegrinsIBA
03/2010 - 11/2002
5tetrapeptide carbamateIBA
11/2005 - 03/2003
5Proteins (Proteins, Gene)FDA Link
11/2005 - 03/2002
4Clopidogrel (Plavix)FDA Link
05/2016 - 04/2002
4Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA
01/2013 - 04/2005
4Contrast MediaIBA
01/2012 - 06/2003
4Phenobarbital (Luminal)FDA Link
01/2011 - 02/2002
3Matrix Metalloproteinases (MMPs)IBA
01/2013 - 11/2005
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2009 - 02/2003
3PPAR gammaIBA
01/2008 - 04/2003
3Insulin (Novolin)FDA Link
01/2008 - 08/2003
2Pharmaceutical PreparationsIBA
05/2016 - 01/2012
2CollagenIBA
12/2014 - 08/2002
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2013 - 04/2002
2SubtilisinIBA
01/2013 - 04/2005
2Fibronectins (Fibronectin)IBA
02/2012 - 08/2002
2Apolipoproteins E (ApoE)IBA
02/2012 - 03/2008
2gadofosveset trisodium (MS 325)FDA Link
01/2012 - 11/2007
2AtropineFDA LinkGeneric
09/2010 - 10/2004
2C-Reactive ProteinIBA
02/2010 - 08/2004
2LigandsIBA
01/2008 - 12/2004
2Coenzyme A (CoA)IBA
02/2006 - 02/2003
2Matrix Metalloproteinase 14 (MT1-MMP)IBA
05/2005 - 08/2004
2Integrin alphaVIBA
02/2004 - 03/2003
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
08/2003 - 05/2002
2Messenger RNA (mRNA)IBA
03/2003 - 08/2002
1Amino AcidsFDA Link
01/2021
1Phenylalanine (L-Phenylalanine)FDA Link
01/2021
1P-SelectinIBA
06/2013
1SelectinsIBA
06/2013
1trkA ReceptorIBA
02/2013
1Nerve Growth Factor (NGF)IBA
02/2013
1InterleukinsIBA
02/2012
1Interleukin-2 (IL2)IBA
02/2012
1sudan IIIIBA
02/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2011
1CD40 Ligand (CD40L)IBA
01/2011
1Insulin-Like Growth Factor I (IGF-1)IBA
04/2010
1Insulin-Like PeptidesIBA
04/2010
1ElementsIBA
07/2009
1Propofol (Diprivan)FDA LinkGeneric
06/2009

Therapy/Procedure

8Therapeutics
05/2016 - 04/2002
4Denervation
12/2014 - 08/2013
4Percutaneous Coronary Intervention
06/2013 - 02/2004
4Stents
01/2008 - 04/2003
3Catheters
09/2014 - 12/2003
2Radiofrequency Ablation
08/2013 - 06/2008
1Sympathectomy (Sympathectomies)
08/2018
1Cryosurgery
01/2015
1Transcatheter Aortic Valve Replacement
07/2014
1Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
02/2012
1Defibrillators (Defibrillator)
02/2012
1Catheter Ablation
12/2009
1Thrombolytic Therapy
09/2009